{"id":"renessans-interferon-alpha-2b-ribavirin","safety":{"commonSideEffects":[{"rate":"50-80","effect":"Flu-like symptoms (fever, fatigue, myalgia)"},{"rate":"10-15","effect":"Hemolytic anemia"},{"rate":"5-10","effect":"Thrombocytopenia"},{"rate":"10-20","effect":"Depression and neuropsychiatric effects"},{"rate":"5-10","effect":"Thyroid dysfunction"},{"rate":"5-10","effect":"Alopecia"},{"rate":"20-30","effect":"Nausea and gastrointestinal disturbance"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Interferon alpha-2b activates natural killer cells and macrophages to mount an antiviral immune response against infected hepatocytes. Ribavirin is a nucleoside analog that inhibits viral RNA-dependent RNA polymerase, reducing hepatitis C virus replication. Together, they work synergistically to clear chronic HCV infection.","oneSentence":"This combination therapy uses interferon alpha-2b to enhance antiviral immune response and ribavirin to inhibit viral replication, targeting hepatitis C virus.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:31:51.205Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic hepatitis C virus infection"}]},"trialDetails":[{"nctId":"NCT01463592","phase":"PHASE3","title":"To Study the Efficacy and Safety of Renessans in Chronic HCV Patients","status":"UNKNOWN","sponsor":"MTI Medical Private Limited, Pakistan","startDate":"2010-06","conditions":"Hepatitis C, Chronic","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["IODINE POLYMER","HEBERON","VIRON"],"phase":"phase_3","status":"active","brandName":"RENESSANS , INTERFERON ALPHA 2b, Ribavirin","genericName":"RENESSANS , INTERFERON ALPHA 2b, Ribavirin","companyName":"MTI Medical Private Limited, Pakistan","companyId":"mti-medical-private-limited-pakistan","modality":"Biologic","firstApprovalDate":"","aiSummary":"This combination therapy uses interferon alpha-2b to enhance antiviral immune response and ribavirin to inhibit viral replication, targeting hepatitis C virus. Used for Chronic hepatitis C virus infection.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}